CLINICAL_TRIALS
trial_result
· 2017-01-11
Clinical Trial Update: Atomoxetine for the Treatment of Cannabis Dependence [Phase 2]
Summary
A Phase 2 clinical trial of atomoxetine for treating cannabis dependence has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cannabis Dependence | Phase 2 | Status: COMPLETED